UnitedHealth
UNH
3,295 hedge funds and large institutions have $248B invested in UnitedHealth in 2025 Q4 according to their latest regulatory filings, with 414 funds opening new positions, 1,116 increasing their positions, 1,495 reducing their positions, and 213 closing their positions.
94% more first-time investments, than exits
New positions opened: 414 | Existing positions closed: 213
19% more call options, than puts
Call options by funds: $20.7B | Put options by funds: $17.4B
4% more funds holding
Funds holding: 3,159 → 3,295 (+136)
1.94% more ownership
Funds ownership: 81.06% → 83% (+1.9%)
2% less capital invested
Capital invested by funds: $253B → $248B (-$5.17B)
21% less funds holding in top 10
Funds holding in top 10: 99 → 78 (-21)
25% less repeat investments, than reductions
Existing positions increased: 1,116 | Existing positions reduced: 1,495
Top Buyers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$817M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$705M |
| 3 |
Amundi
Paris,
France
|
+$523M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$503M |
| 5 |
Bank of New York Mellon
New York
|
+$477M |
Top Sellers
UNH Hedge Fund Activity: Q4 2025 in Review
3,295 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in UnitedHealth (UNH) for Q4 2025, worth a combined $248B — down 2% from $253B a quarter earlier.
Buyers outnumbered sellers: 414 funds opened new UNH positions and 213 closed out — a net gain of 201 holders — while 1,116 added to existing stakes and 1,495 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $817M. The largest seller was Capital Research Global Investors, cutting an estimated $2.3B.
- 3,295 institutional investors held UnitedHealth (UNH) as of Q4 2025, up from 3,159 in Q3 2025.
- Funds reported $248B of UnitedHealth stock for Q4 2025, down 2% quarter-over-quarter.
- 414 funds opened new UnitedHealth positions in Q4 2025 and 213 closed out, a net change of +201 holders.
- The largest UnitedHealth buyer in Q4 2025 was T. Rowe Price Investment Management, an estimated $817M added.
- The largest UnitedHealth seller in Q4 2025 was Capital Research Global Investors, an estimated $2.3B sold.
Based on aggregated 13F filings for Q4 2025.